<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM/HYPOTHESIS: The plasma activity of <z:chebi fb="0" ids="16247">phospholipid</z:chebi> transfer protein (PLTP), which has putative pro- and anti-atherogenic roles in <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism, is increased in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We analysed the relationship between carotid artery intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>), an established marker of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, and PLTP activity in diabetic patients and control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> (mean of three segments in both carotid arteries by ultrasonography), clinical variables, plasma PLTP activity (<z:chebi fb="0" ids="16247">phospholipid</z:chebi> vesicle-<z:chebi fb="17" ids="39025">HDL</z:chebi> system), <z:chebi fb="2" ids="6495">lipoproteins</z:chebi>, C-reactive protein and insulin were measured in 87 non-smoking men and women, who had type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, no <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, and were not on insulin or <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering medication, and in 83 age-matched control subjects </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In diabetic patients, carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> (p=0.02), pulse pressure (p=0.003), plasma PLTP activity (p&lt;0.001), <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (p=0.01), C-reactive protein (p&lt;0.01) and insulin (p&lt;0.001) were higher, whereas <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> was lower (p&lt;0.001) than in control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>Multiple stepwise linear regression analysis demonstrated that in type 2 diabetic patients <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was independently associated with age (p&lt;0.001), sex (p=0.001), pulse pressure (p=0.003), plasma PLTP activity (p=0.03) and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (p=0.03), but not with <z:chebi fb="0" ids="39027">very low density lipoprotein</z:chebi>+<z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi>, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, C-reactive protein and insulin (<z:hpo ids='HP_0000001'>all</z:hpo> p&gt;0.20) </plain></SENT>
<SENT sid="5" pm="."><plain>The relationship between plasma PLTP activity and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was not significant in control subjects </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS/INTERPRETATION: Plasma PLTP activity is a positive determinant of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, suggesting that high PLTP activity is involved in <z:hpo ids='HP_0004943'>accelerated atherosclerosis</z:hpo> in this disease </plain></SENT>
</text></document>